Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BCL7A Antikörper (C-Term)

BCL7A Reaktivität: Human, Maus, Ratte WB, ICC, IF, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN2854648
  • Target Alle BCL7A Antikörper anzeigen
    BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))
    Bindungsspezifität
    • 15
    • 8
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term
    Reaktivität
    • 33
    • 7
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Human, Maus, Ratte
    Wirt
    • 32
    • 1
    Kaninchen
    Klonalität
    • 33
    Polyklonal
    Konjugat
    • 16
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser BCL7A Antikörper ist unkonjugiert
    Applikation
    • 26
    • 18
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunocytochemistry (ICC), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Produktmerkmale
    Rabbit Polyclonal antibody to BCL7A (B-cell CLL/lymphoma 7A)
    BCL7A antibody [C2C3], C-term
    Aufreinigung
    Purified by antigen-affinity chromatography.
    Immunogen
    Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human BCL7A. The exact sequence is proprietary.
    Isotyp
    IgG
  • Applikationshinweise
    Suggested dilution Reference ICC/IF 1:100-1:1000* IHC (Formalin-fixed paraffin-embedded sections) 1:100-1:1000* Western blot 1:500-1:3000* Not tested in other applications. *Optimal dilutions/concentrations should be determined by the researcher.Suggested dilutionReferenceICC/IF1:100-1:1000* IHC (Formalin-fixed paraffin-embedded sections)1:100-1:1000* Western blot1:500-1:3000*
    Kommentare

    Positive Control: HeLaS3 , Neuro2A , GL261

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 mg/mL
    Buffer
    1XPBS, 20 % Glycerol ( pH 7). 0.01 % Thimerosal was added as a preservative.
    Konservierungsmittel
    Thimerosal (Merthiolate)
    Vorsichtsmaßnahmen
    This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Keep as concentrated solution. Aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
  • Target
    BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))
    Andere Bezeichnung
    BCL7A (BCL7A Produkte)
    Synonyme
    BCL7 antikoerper, cb585 antikoerper, id:ibd1097 antikoerper, sb:cb585 antikoerper, wu:fk02d01 antikoerper, zgc:92023 antikoerper, 4432415N06Rik antikoerper, AI448316 antikoerper, bcl7a antikoerper, MGC89576 antikoerper, BCL7A antikoerper, BCL tumor suppressor 7A antikoerper, B-cell CLL/lymphoma 7A antikoerper, B cell CLL/lymphoma 7A antikoerper, B-cell CLL/lymphoma 7A L homeolog antikoerper, BCL7A antikoerper, bcl7a antikoerper, Bcl7a antikoerper, bcl7a.L antikoerper
    Hintergrund
    This gene is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C. Two transcript variants encoding different isoforms have been found for this gene.

    Molekulargewicht
    23 kDa
    Gen-ID
    605
Sie sind hier:
Kundenservice